Atara Biotherapeutics, Inc. ( ATRA) - Key Metrics
ATRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$0.32 | -$0.22 | -$0.22 |
| 2026Q1 | $0.04 | -$0.29 | -$0.22 | -$0.22 |
| 2025Q4 | $0.13 | -$0.27 | -$0.45 | -$0.45 |
| 2025Q3 | $0.25 | -$0.32 | -$0.72 | -$0.72 |
| 2025Q2 | $1.44 | $0.20 | -$0.60 | -$0.60 |
ATRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.97 |
| 2026Q1 | 0% | -4.08 |
| 2025Q4 | 0% | -18.09 |
| 2025Q3 | 0% | -11.20 |
| 2025Q2 | 0% | 9.65 |
ATRA
Price: $8.09
52 week price:
Earnings Per Share: -1.26 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 783100
Ebitda: -31.4 millionMarket Capitalization: 83.1 million